MedPath

Effect of topical fluorouracil on vitiligo

Phase 2
Recruiting
Conditions
vitiligo.
Vitiligo
Registration Number
IRCT20180602039939N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Age above 10 years
Refractory lesions after 3 month of NB-UVB therapy
Lesions distal to elbow/knee (except palms and soles)
Signed written informed consent

Exclusion Criteria

Active cobner phenomenon at the lesion site
Active infection at the lesion site
Lesions more than 10 cm
Pregnancy/breastfeeding
Bleeding diseases
Immunosuppress patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Re-pigmentation ratio;. Timepoint: Each 2 weeks until 3 months. Method of measurement: Scoring according to the dermatologist diagnosis.
Secondary Outcome Measures
NameTimeMethod
Re-pigmentation start time. Timepoint: Each 2 weeks until 3 months. Method of measurement: Scoring according to dermatologist diagnosis.
© Copyright 2025. All Rights Reserved by MedPath